BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37352786)

  • 21. Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology.
    Dessauvagie BF; Lee AHS; Meehan K; Nijhawan A; Tan PH; Thomas J; Tie B; Treanor D; Umar S; Hanby AM; Millican-Slater R
    J Clin Pathol; 2018 Aug; 71(8):672-679. PubMed ID: 29440134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation.
    Yilmaz A; Rush DS; Soslow RA
    Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases.
    Suster D; Michal M; Nishino M; Piana S; Bongiovanni M; Blatnik O; Hájková V; Ptáková N; Michal M; Suster S
    Mod Pathol; 2020 Sep; 33(9):1702-1711. PubMed ID: 32291398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.
    Cîmpean AM; Raica M; Nariţa D
    Rom J Morphol Embryol; 2005; 46(2):123-9. PubMed ID: 16286998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast hamartoma: reassessment of an under-recognised breast lesion.
    Alran L; Chamming's F; Auriol-Leizagoyen S; Velasco V; Deleau F; Brouste V; Bonhomme B; Ben Rejeb H; Marty M; MacGrogan G
    Histopathology; 2022 Jan; 80(2):304-313. PubMed ID: 34403159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
    Li JJX; Tse GM
    Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD117 and CD34 staining patterns in childhood benign mammary lesions.
    Kaçar A; Paker I; Akbiyik F; Arikök AT; Mambet E
    Turk Patoloji Derg; 2012; 28(1):31-7. PubMed ID: 22207429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myoid hamartomas of the breast: report of 3 cases and review of the literature.
    Filho OG; Gordan AN; Mello Rde A; Neto CS; Heinke T
    Int J Surg Pathol; 2004 Apr; 12(2):151-3. PubMed ID: 15173923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway.
    Catteau X; Simon P; Noël JC
    BMC Cancer; 2014 Jul; 14():499. PubMed ID: 25011545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues.
    Sappino AP; Skalli O; Jackson B; Schürch W; Gabbiani G
    Int J Cancer; 1988 May; 41(5):707-12. PubMed ID: 2835323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determining whether excision of all fibroepithelial lesions of the breast is needed to exclude phyllodes tumor: upgrade rate of fibroepithelial lesions of the breast to phyllodes tumor.
    Van Osdol AD; Landercasper J; Andersen JJ; Ellis RL; Gensch EM; Johnson JM; De Maiffe B; Marcou KA; Al-Hamadani M; Vang CA
    JAMA Surg; 2014 Oct; 149(10):1081-5. PubMed ID: 25162470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors.
    Marcil G; Wong S; Trabulsi N; Allard-Coutu A; Parsyan A; Omeroglu A; Atinel G; Mesurolle B; Meterissian S
    Am J Surg; 2017 Aug; 214(2):318-322. PubMed ID: 28057293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hamartoma of the breast.
    Riveros M; Cubilla A; Perotta F; Solalinde V
    J Surg Oncol; 1989 Nov; 42(3):197-200. PubMed ID: 2811385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroepithelial tumours of the breast-a review.
    Lerwill MF; Lee AHS; Tan PH
    Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
    Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
    Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Characterization of Myoid Hamartoma of the Breast.
    Panagopoulos I; Gorunova L; Andersen HK; Pedersen TD; Lømo J; Lund-Iversen M; Micci F; Heim S
    Cancer Genomics Proteomics; 2019; 16(6):563-568. PubMed ID: 31659109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital smooth muscle hamartoma of the nipple: a case report.
    Szychta P; Dixon M; Raine C
    Anal Quant Cytopathol Histpathol; 2012 Oct; 34(5):285-8. PubMed ID: 23301388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine-needle aspiration cytology of spindle cell lesions of the breast.
    Chhieng DC; Cangiarella JF; Waisman J; Fernandez G; Cohen JM
    Cancer; 1999 Dec; 87(6):359-71. PubMed ID: 10603190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelioid cells in myoid hamartoma of the breast: a potential diagnostic pitfall for core biopsies.
    Garfein CF; Aulicino MR; Leytin A; Drossman S; Hermann G; Bleiweiss IJ
    Arch Pathol Lab Med; 1996 Jul; 120(7):676-80. PubMed ID: 8757475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey of recurrent diagnostic challenges in breast phyllodes tumours.
    Tan BY; Fox SB; Lakhani SR; Tan PH
    Histopathology; 2023 Jan; 82(1):95-105. PubMed ID: 36468287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.